You just read:

Heptares and PeptiDream Enter Strategic Collaboration to Discover, Develop and Commercialise Novel Therapeutics in Inflammatory Disease

News provided by

Heptares Therapeutics and PeptiDream

Jun 29, 2017, 03:00 ET